Characteristics of autoimmune hepatitis in the Asia-Pacific Region: historical review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kunkel HG, Ahrens JR, Eisenmenger WJ, Bongiovanni AM, Slater RJ. Extreme, hypergammaglobulinemia in young women with liver disease of unknown etiology (abstract). J Clin Invest 1951;30:654
Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of cDNA clone derived from a blood-borne non-A, nonB viral hepatitis genome. Science 1989;244:359–362
Ohta Y, Onji M. Clinical characteristics of autoimmune hepatitis in Japan. In Nishioka M, Toda G, Zeniya M (eds) Elsevier, Amsterdam, 1994. p. 45–53
Zeniya M, Kuramoto A, Takahashi H, Aizawa Y, Toda G. The present status of autoimmune hepatitis and its heterogeneity. In Yamanaka M, Okabe K, Toda G, editors. Progress in hepatology, vol 1. Amsterdam: Elsevier; 1995. p. 101–118
Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan-correlating the characteristics with international criteria in an area with high rate of HCV infection. J Hepatol 1997;26:1207–1212
Abe M, Mashiba T, Zeniya M, Yamamoto K, Onji M, Tsubouchi H. Present status of autoimmune hepatitis in Japan: a nationwide survey. J gastroenterol 2011 (in press)
Alvarez F, Berg PA, Bianchi FB, et al. International autoimmune hepatitis Group report review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929–938
Mackay IR, Tait BD. HLA association with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 1980;79:95–98
Zeniya M, Watanabe F, Aizawa Y, Toda G. Genetic background of autoimmune hepatitis in Japan. In Nishioka M, Toda G, Zeniya M, editors. Autoimmune hepatitis. Amsterdam: Elsevier; 1994. p. 267–279
Nishioka M, Morshed SA, McFarlane IG, Vergani D, Nomberg J-C, Penner E, Socha J, Porta G. Geographical variation in the Frequency and characteristics of autoimmune liver diseases. In Krawitt E, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases. 2nd ed. Amsterdam: Elsevier; 1998. p. 9413–24
Mackay IR. Chronic active hepatitis, cirrhosis and other diseases of liver. In Samter M, editor. Immunological diseases. 3rd ed. Boston: Little Brown; 1978. p. 1454–1477
Mistilis SP, Skyring AP, ZBlackburn CRB. Natural history of active chronic hepatitis. 1. Clinical features, course, diagnostic criteria, morbidity and survival. Australas Ann Med 1968;17:214–223
Toda G, Watanabe F, Zeniya M. Autoimmune hepatitis:an epidemiological study. Nippon Naika Gakkai Zasshi 1988;88:572–577 (Japanese)
Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with HLA-Bw54and DR4 in Japanese patients. Hepatology 1990;12:1300–1304
Donaldson PT, Doherty DG, Hayller KM, et al. Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigensDR4and A1-B8-DR3 are independent risk factors. Hepatology 1991;13:701–706
Doherty DG, Donaldson PT, Underhill JA, et al. Allelic sequence variation in the HLA class II genes and protein in patients with autoimmune hepatitis. Hepatology 1994;19:609–615
Fainboim L, Velasco MCC, Marcos CY. Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB1*1301, a marker for paediatric autoimmune hepatitis. Hepatology 2001;33:1512–1517
Gupta R, Agarwal SR, Jain M, Malhotra V, Sarin SK. Autoimmune hepatitis in the Indian subcontinent: 7 years experience. J Gastroenterol Hepatol 2001;16:1144–1148
Gohar S, Desai D, Joshi A, et al. Autoimmune hepatitis: a study of 50 patients. Indian J Gastroenterol 2003;22:140–142
Choudhuri G, Somani SK, Baba CS, Alexander G. Autoimmune hepatitis in India: profile of an uncommon disease. BMC Gastroenterol 2005;5:27
Amarapurkar DN, Patel ND. Spectrum of autoimmune liver diseases in western India. J Gastroenterol Hepatol 2007;22:2112–2117
Lee YM, Teo EK, Ng TM, Khor C, Fock KM. Autoimmune hepatitis in Singapore: a rare syndrome affecting middle-aged women. J Gastroenterol Hepatol 2001;16:1384–1389
Huang HC, Huang YS, Wu JC, et al. Characteristics of autoimmune hepatitis in Taiwan: the 11 years’ experiences of a medical center. Zhonghua Yi Xue Za Zhi (Taipei) 2002;65:563–569
Koay LB, Lin CY, Tsai SL, et al. Type 1 autoimmune hepatitis in Taiwan: diagnosis using the revised criteria of the International Autoimmune Hepatitis Group. Dig Dis Sci 2006;51:1978–1984
Kil JS, Lee JH, Han AR, et al. Long-term treatment outcomes for autoimmune hepatitis in Korea. J Korean Med Sci 2010;25:54–60
Haider AS, Kaye G, Thomson A. Autoimmune hepatitis in a demographically isolated area of Australia. Intern Med J 2010;40:281–285
Kosar Y, Kacar S, Sasmaz N, et al. Type 1 autoimmune hepatitis in Turkish patients. J Clin Gastroenterol 2002;35:185–190
Lim YS, Oh HB, Choi HE, et al. Susceptibility to type 1 autoimmune hepatitis is associated with shared amino acid sequences at positions 70–74 of the HLA-DRB1 molecule. J Hepatol 2008;48:133–139
Vergani D, Alverez F, Bianchi FB, et al. Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International autoimmune hepatitis Group. J Hepatol 2004;41:677–683
Manns MJ, Czaja AJ, Gorhan JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193–2213
Takahashi H, Zeniya M (submitting).